BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8897704)

  • 1. Hematopoietic effects and clinical application of granulopoietic growth factors.
    Höglund M
    Ups J Med Sci; 1996; 101(2):121-48. PubMed ID: 8897704
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of recombinant GM-CSF and G-CSF on the bone marrow cells of children with acute lymphoblastic leukemia.
    Ode DL; Zhou M; Findley HW; Abdel-Mageed A; Ragab AH
    Leukemia; 1992 Nov; 6(11):1210-2. PubMed ID: 1279325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological therapies in bone marrow transplantation.
    Kochupillai V
    Indian J Med Res; 1995 Apr; 101():129-33. PubMed ID: 7538493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of exogenous recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor on neutrophil function following allogeneic bone marrow transplantation.
    Fabian I; Kletter Y; Bleiberg I; Gadish M; Naparsteck E; Slavin S
    Exp Hematol; 1991 Oct; 19(9):868-73. PubMed ID: 1716591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the clinical use of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor to intensify cancer chemotherapy.
    Fisher DC; Peters WP
    Curr Opin Hematol; 1994 May; 1(3):221-7. PubMed ID: 9371286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colony-stimulating factors in cancer therapy.
    Morstyn G; Sheridan WP
    Cancer Chemother Biol Response Modif; 1992; 13():308-26. PubMed ID: 1382528
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of hematopoiesis in bone marrow cultures from patients with chronic myeloid leukemia: effect of recombinant cytokines in dexter-type long-term cultures.
    Luna-Bautista F; Sánchez-Valle E; Ayala-Sánchez M; Morales-Polanco M; Meillon-García L; Benítez-Bribiesca L; Mayani H
    Hematology; 2003 Jun; 8(3):155-63. PubMed ID: 12745649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and sustained allogeneic transplantation using immunoselected CD34(+)-selected peripheral blood progenitor cells mobilized by recombinant granulocyte- and granulocyte-macrophage colony-stimulating factors.
    Corringham RE; Ho AD
    Blood; 1995 Sep; 86(5):2052-4. PubMed ID: 7544651
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune system boosters set for FDA go-ahead.
    Marwick C
    JAMA; 1991 Feb; 265(7):841-2. PubMed ID: 1704069
    [No Abstract]   [Full Text] [Related]  

  • 11. [Autotransplantation in acute leukemia using totipotent cells mobilized with filgrastim].
    Ruiz-Argüelles GJ; Ruiz-Argüelles A; Alemán-Hoey DD; Arizpe Bravo D; Martin-López A; Ocejo Rodríguez A
    Rev Invest Clin; 1993; 45(5):479-80. PubMed ID: 7510900
    [No Abstract]   [Full Text] [Related]  

  • 12. Observations on the effects of hematopoietic colony-stimulating factors on the clinical course of bone marrow transplantation.
    Peters WP
    Recent Results Cancer Res; 1993; 132():97-101. PubMed ID: 7505472
    [No Abstract]   [Full Text] [Related]  

  • 13. Hematopoietic growth factors in cancer chemotherapy.
    Morstyn G; Lieschke GJ
    Cancer Chemother Biol Response Modif; 1994; 15():367-90. PubMed ID: 7540031
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid recovery of hematopoiesis in patients given high-dose chemotherapy followed by infusion of refrigerated unprocessed autologous bone marrow and peripheral blood.
    Aggarwal S; Singh B; Sood SK; Kumra VP; Byotra SP; Sachar VP; Saran RK
    Transplant Proc; 2000 Nov; 32(7):2460-1. PubMed ID: 11120244
    [No Abstract]   [Full Text] [Related]  

  • 15. Morphologic and quantitative alterations in hematopoietic cells associated with growth factor therapy: review of the literature.
    Schmitz LL; Litz CE; Brunning RD
    Hematol Pathol; 1994; 8(3):55-73. PubMed ID: 7527020
    [No Abstract]   [Full Text] [Related]  

  • 16. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hematopoietic growth factors].
    Robak T
    Postepy Hig Med Dosw; 1991; 45(6):461-96. PubMed ID: 1726024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor.
    Molineux G; Pojda Z; Hampson IN; Lord BI; Dexter TM
    Blood; 1990 Nov; 76(10):2153-8. PubMed ID: 1700732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals.
    Anderlini P; Przepiorka D; Champlin R; Körbling M
    Blood; 1996 Oct; 88(8):2819-25. PubMed ID: 8874177
    [No Abstract]   [Full Text] [Related]  

  • 20. Hematopoietic growth factors and acute leukemia.
    Rowe JM; Liesveld JL
    Cancer Treat Res; 1999; 99():195-226. PubMed ID: 9891868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.